ISOPTO ATROPINE

This brand name is authorized in Canada, Estonia, United States

Active ingredients

The drug ISOPTO ATROPINE contains one active pharmaceutical ingredient (API):

1 Atropine UNII 03J5ZE7KA5 - ATROPINE SULFATE

Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system. Read about Atropine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ISOPTO ATROPINE Ophthalmic solution	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01FA01	Atropine	S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FA Anticholinergics
Discover more medicines within S01FA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00035017
Country: EE	Ravimiamet	Identifier(s): 1138676
Country: US	FDA, National Drug Code	Identifier(s): 0065-0303